Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

A new study finds that a shingles vaccination cut older adults’ risk of developing dementia over the next seven years by 20%.

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

Despite an R&D spend of around $15bn, a total of 20 beta amyloid protein-targeting drugs have failed to show efficacy in phase II and III studies involving AD patients, and pharma companies are ...

Roche Holding said it will initiate a late-stage trial for its Alzheimer's drug candidate trontinemab later this year after its mid-stage study showed positive results.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna, ...